 MINNEAPOLIS, July 07, 2021 GLOBE NEWSWIRE -- Panbela Therapeutics, Inc. Nasdaq: PBLA, a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that the company will present at Access to Giving Virtual Conference. The presentation will be given by Panbelas President Chief Executive Officer, Jennifer K. Simpson, PhD, MSN, CRNP. 